Dynatrace (DT) Stock | DT Stock Price & Analysis

Feed

Dynatrace DT · NYSE

$61.09 -4.14% (-$2.64)

Summary

63 / 100 · Bulios Score

Valuation 44Growth 90Profitability 70Quality 28Debt 88Stability 69

What speaks for it

Earnings per share grew by 107% a year over the last 3 years.
It holds more cash than debt: $1.06B against $159.3M.
Out of every 100 USD of revenue, 27 USD is left as free cash.
Analysts expect revenue to grow by 18% this fiscal year.

What to watch

The share price is above the Bulios Fair Price.
It earns only 5.1 USD a year on every 100 USD of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive

Bulios Fair Price

Current price $61.09

5-year average P/E 135.5 9.8% lower

P/E today 122.2

Software - Application industry median

P/E today 122.2

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 122.2 USD for 1 USD of yearly profit. Over the last five years it was 135.5 USD on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

704M

929M

1.2B

1.4B

1.7B

2.0B

2.3B

2021202220232024202520262027

Diluted EPS (USD)

$0.26

$0.18

$0.37

$0.52

$1.59

$1.68

$1.98

2021202220232024202520262027

Analyst estimate

Revenue grew by 25% a year over 5 years. Over the last 3 years it grew by 22% a year. For the next fiscal year analysts expect revenue to grow by 18%. Earnings per share grew by 107% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Cost of sales 19 USD
Research and development 24 USD
Sales and administration 44 USD
Taxes and other 5.8 USD
Net profit 7.2 USD

Net profit, industry median (Software - Application) 7.5 USD

Out of every 100 USD of revenue, 7.2 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Cash and short-term investments $1.11B

Debt $159.3M

Free cash flow over 12 months $568.1M

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Buy 30
Hold 5
Sell 0

Today's price within the analysts' price targets

Today's price $61.09 Average target $62.44

$42 $75

The average target of $62.44 is 2.2% above today's price. 86% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2026

By product

Subscription and Circulation 96%
Service 4.4%

By region

North America 50%
EMEA 32%
Asia Pacific 9.6%
Latin America 7.9%

Subscription and Circulation brings in 96% of revenue.

Segments in detail